Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Araclon Biotech

Araclon Biotech
2004 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
Description

Provider of biotechnology related services. Developer of therapies and diagnostic methods for Alzheimer's disease. The company focuses on research and development of therapies and diagnostic methods to be applied to degenerative diseases.

Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Parent Company
Primary Office
  • Vía Hispanidad
  • 21 50009 Zaragoza
  • Spain

+34 976 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Araclon Biotech’s full profile, request a free trial.

Araclon Biotech Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 15-Mar-2012 Completed Generating Revenue
2. IBO 15-Feb-2012 Completed Generating Revenue
1. Early Stage VC Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Araclon Biotech Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Going Investment Venture Capital Minority 000 0000 000000 0
Mobius Venture Capital Venture Capital Minority 000 0000 000000 0
VIA Technologies Corporation Minority 000 0000 000000 0

Araclon Biotech Executive Team (1)

Name Title Board
Seat
Contact
Info
Manuel Sarasa Founder, Chief Executive Officer & Chief Scientific Officer